SIGNiX, Exostar Partner in Digital Signatures
SIGNiX, an e-signature provider, and Exostar, an information technology company offering cloud-based solutions that enable secure, cost-effective business-to-business collaboration, announced a relationship that brings SIGNiX’s digital signature solution to Exostar’s life sciences and healthcare communities. With SIGNiX becoming Exostar’s latest Application Partner, organizations and individuals connected to Exostar's Life Sciences Identity Hub can leverage secure, single sign-on access to SIGNiX to quickly and easily sign business-critical and sensitive documents and forms online.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025